UPDATED 18:46 PM EST, January 16, 2013
WASHINGTON (AP) — For the nearly 30 million Americans who suffer from a rare disease, there's heartening news: Drugmakers have been shifting much of their research away from pills for the millions to uncommon disorders that often kill prematurely because there are few or no treatment options.




